InvestorsHub Logo
Followers 129
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: None

Friday, 02/26/2021 4:45:33 PM

Friday, February 26, 2021 4:45:33 PM

Post# of 199475
ENZC is continuing to make progress on their quest to bring products to the market.

We have gotten many updates expectantly and unexpectedly.

The PCAOB is not an easy task and will probably take until April as Charles said if not longer. Doing one yearly audit is tough enough however doing 2 yearly audits isn’t a cakewalk.

ENZC has different avenues available to get the process moving further along:

Coronavirus Treatment Acceleration Program
https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap

FDA Emergency Use Authorization
http://www.ctinmateinfo.state.ct.us/resultsupv.asp

FDA Investigational New Drug (IND) Application
https://www.fda.gov/drugs/types-applications/investigational-new-drug-ind-application

Operation Warp Speed(if invited)
https://www.defense.gov/Explore/Spotlight/Coronavirus/Operation-Warp-Speed/

Regardless of which avenue ENZC takes continued funding will be necessary for further progress. It could come from grants, dilution (not saying it will just listing it as an avenue), undisclosed partner or through one of the government programs available to fight Covid-19.

ENZC has released a stream of information that suggesting they the ability to provide therapeutic solutions solving the virus escape problem, countering any variants to viruses and doing so with little or no toxicity.

Speaking of toxicity, ENZC is awaiting results from testing that is necessary for them to submit an IND application to the FDA. All information provided thus far from ENZC suggests that have little or no toxicity in their therapeutics so the test result should have a positive impact on the company.

ENZC has done a lot in the past 6 months. We have not been informed yet of very company changing catalysts such as funding, application submissions or results for certain tests. However we had surprises such as the patent applications and setbacks as the Bulgaria situation. ENZC has moved forward and onward regardless of the good, bad and hopefully never ugly situations. They are in a good position to succeed as long as they press forward, are properly funded and keep the pedal to the medal as they have been doing.